GLYCEMIC CONTROL AND CARDIO-RENO-VASCULAR PROTECTION , BENEFITS THAT GO HAND IN HAND.

How can we manage the high prevalence of CV diabetes-related complications and improve the quality of life of our patients?

CVD is the leading cause of morbidity and mortality among patients with T2D. One of the main factors that affects this risk, is the lack of control of HbA1c>7.

Click and discover in the following talk how two experts in the management of type 2 diabetes provide a review of what strategies we have available as specialists to reduce the risk of complications, focusing on the importance of glycemic control and implementing a personalized lifestyle for the patient with T2D.